Feb 20 (Reuters) - Cyclopharm Ltd (CYC) :
- RESOLVED TO PAY FINAL UNFRANKED DIVIDEND OF 0.5 AU CENTS PER SHARE
- FY PRELIMINARY REVENUES FROM ORDINARY ACTIVITIES UP 31.1% TO A$23.2 MILLION
- REMAINS CONFIDENT THAT EXPECTATIONS OF TRIAL RESULTS BEING PUBLISHED IN FIRST HALF OF 2023 WILL BE MET
- FY LOSS FOR THE YEAR A$6.6 MILLION VERSUS LOSS A$5.0 MILLION
- CONTINUES TO PROGRESS TOWARD ATTAINING USFDA APPROVAL TO COMMENCE COMMERCIAL SALES OF TECHNEGAS IN US MARKET IN 2023
- POISED TO ENTER ITS NEXT GROWTH PHASE IN 2023
Feb 20 (Reuters) - Cyclopharm Ltd (CYC) : RESOLVED TO PAY FINAL...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
98.0¢ |
Change
0.010(1.03%) |
Mkt cap ! $107.8M | |||
| Open | High | Low | Value | Volume |
| 97.5¢ | 98.0¢ | 97.0¢ | $18.59K | 19.12K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 28138 | 97.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 98.5¢ | 3679 | 2 |
View Market Depth
| Last trade - 11.18am 20/06/2025 (20 minute delay) ? |
| CYC (ASX) Chart |